NCT00004199View on ClinicalTrials.gov

Prinomastat and Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Non-small Cell Lung Cancer

PHASE3CompletedINTERVENTIONAL

Timeline

Start Date

March 31, 1999

Primary Completion Date

July 31, 2001

Conditions

Lung Cancer

Interventions

DRUG

cisplatin

DRUG

gemcitabine hydrochloride

DRUG

prinomastat

Trial Locations (1)

92037

Agouron Pharmaceuticals, Inc., La Jolla

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY